Moxifloxacin
Moxifloxacin is a pharmaceutical drug with 306 clinical trials. Currently 11 active trials ongoing. Historical success rate of 96.0%.
Success Metrics
Based on 262 completed trials
Phase Distribution
Phase Distribution
216
Early Stage
32
Mid Stage
43
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.2%
262 of 278 finished
5.8%
16 ended early
11
trials recruiting
306
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study in Healthy People to Test How Vicadrostat Affects the Heart
Shortened Regimen for Drug-susceptible TB in Children
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
Clinical Trials (306)
A Study in Healthy People to Test How Vicadrostat Affects the Heart
Shortened Regimen for Drug-susceptible TB in Children
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
A Study To Evaluate The Effect Of A Supratherapeutic Dose Of Elpipodect (MK-8189) On The QTc Interval In Participants With Schizophrenia (MK-8189-019)
A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)
Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities
Treatment of Mycobacterium Xenopi Pulmonary Infection
A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 306